Literature DB >> 7930377

Thyroid ultrasonography in patients with a previous episode of amiodarone induced thyrotoxicosis.

E Roti1, L Bianconi, F De Chiara, R Minelli, C Tosi, E Gardini, M Salvi, L E Braverman.   

Abstract

Amiodarone induced thyrotoxicosis (AIT) occurs most frequently in euthyroid patients with nodular goiter or Graves' disease due to release of iodine from this iodine rich drug. However, some cases of AIT have been attributed to an inflammatory process of the thyroid gland due to amiodarone itself. We have studied the echographic pattern of the thyroid in 11 euthyroid patients who had an episode of AIT 32.4 +/- 3.6 months earlier due to amiodarone induced thyroiditis. There was a significant increase in dyshomogeneous echo patterns and hyperechogenecity which suggests fibrotic lesions. These findings were similar to those observed in 10 euthyroid patients who 77 +/- 12 months earlier had an episode of subacute thyroiditis (SAT). Thyroid volumes of control subjects and patients with a history of AIT and SAT were 10.9 +/- 1.4, 8.7 +/- 1.4 and 9.8 +/- 1.7, in the order. These values were not significantly different. These echographic findings, normal serum thyroid hormone and TSH concentrations and the absence of circulating antithyroid peroxidase antibodies suggest that underlying thyroid autonomy and Graves' disease were not the cause of the previous episode of AIT. The presence of hyperechogenic and dyshomogeneous patterns appears the result of the healing of the inflammatory AIT process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930377     DOI: 10.1007/BF03348972

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  Thyroid ultrasonography related to clinical and laboratory findings in patients with silent thyroiditis.

Authors:  M Miyakawa; T Tsushima; N Onoda; M Etoh; O Isozaki; M Arai; K Shizume; H Demura
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

2.  Thyroid hypoechogenic pattern at ultrasonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves' disease.

Authors:  P Vitti; T Rago; F Mancusi; S Pallini; M Tonacchera; F Santini; L Chiovato; C Marcocci; A Pinchera
Journal:  Acta Endocrinol (Copenh)       Date:  1992-02

3.  Pathology of the thyroid in amiodarone-associated thyrotoxicosis.

Authors:  T C Smyrk; J R Goellner; M D Brennan; J A Carney
Journal:  Am J Surg Pathol       Date:  1987-03       Impact factor: 6.394

4.  [Thyroid echography in chronic autoimmune lymphocytic thyroiditis].

Authors:  P Espinasse
Journal:  J Radiol       Date:  1983-10

5.  Amiodarone-induced thyrotoxicosis suggestive of thyroid damage.

Authors:  M Lambert; J Unger; P De Nayer; C Brohet; D Gangji
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

6.  Ultrasonography related to clinical and laboratory findings in lymphocytic thyroiditis.

Authors:  R Gutekunst; W Hafermann; T Mansky; P C Scriba
Journal:  Acta Endocrinol (Copenh)       Date:  1989-07

7.  Painful autoimmune thyroiditis occurring on amiodarone therapy.

Authors:  B Gudbjörnsson; A Kristinsson; G Geirsson; A B Hreidarsson
Journal:  Acta Med Scand       Date:  1987

8.  Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.

Authors:  E Roti; R Minelli; E Gardini; L Bianconi; L E Braverman
Journal:  Arch Intern Med       Date:  1993-04-12

9.  Ultrasound appearances in de Quervain's subacute thyroiditis with long-term follow-up.

Authors:  A Brander
Journal:  J Intern Med       Date:  1992-10       Impact factor: 8.989

Review 10.  Ultrasound evaluation of thyroid diseases.

Authors:  B Leisner
Journal:  Horm Res       Date:  1987
View more
  1 in total

Review 1.  Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.

Authors:  C M Newman; A Price; D W Davies; T A Gray; A P Weetman
Journal:  Heart       Date:  1998-02       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.